Collectively these data identify SMARCD3 as a SWI/SNF subunit that is required for the growth of aggressive cancer stem cells and that exerts its influence by regulating the metabolic landscape in pancreatic cancer. This evidence concerns the gene SMARCD3 and familial pancreatic carcinoma.